Clinical Practice Guideline: Cerumen Impaction
This Clinical Practice Guideline is currently undergoing an update.
Update Leadership: Seth R. Schwartz, MD, MPH (Chair), Anthony E. Magit, MD (Assistant Chair), Richard M. Rosenfeld, MD, MPH (Methodologist)
Guideline Update Group: Bopanna B. Ballachanda, PhD, Jesse M. Hackell, MD, Helen J. Krouse, PhD RN, Claire M. Lawlor, MD, Kenneth Lin, MD, MPH, Kourosh Parham, MD, PhD, David R. Stutz, MD, Sandra Walsh, BS, Erika A. Woodson, MD, Ken Yanagisawa, MD
Timeline: Public Comment January 2016 (tentative) - Publication May 2016 (tentative)
The information below is from the original publication.
The original guideline was published as a supplement in the September 2008 issue of Otolaryngology - Head and Neck Surgery.
Leadership: Timothy L. Smith, MD, MPH (Chair), Peter S. Roland, MD (Assistant Chair), Seth R. Schwartz, MD, MPH (Assistant Chair), Richard M. Rosenfeld, MD, MPH (Methodologist)
Guideline Development Group: Bopanna Ballachanda, PhD, Jerry M. Earll, MD, Jose Fayad, MD, Allen D. Harlor Jr, MD, Barry E. Hirsch, MD, Helene J. Krouse, PhD, Anthony Magit, MD, Carrie Nelson, MD, MS, David R. Stutz, MD, Stephen Wetmore, MD, MBA
The primary purpose of this guideline is to improve diagnostic accuracy for cerumen impaction, promote appropriate intervention in patients with cerumen impaction, highlight the need for evaluation and intervention in special populations, promote appropriate therapeutic options with outcomes assessment, and improve counseling and education for prevention of cerumen impaction.